LivaNova PLC (LIVN)
51.18
-0.44
(-0.85%)
USD |
NASDAQ |
Dec 04, 16:00
51.18
0.00 (0.00%)
After-Hours: 20:00
LivaNova Revenue (Quarterly): 318.12M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 318.12M |
| June 30, 2024 | 318.58M |
| March 31, 2024 | 294.91M |
| December 31, 2023 | 310.13M |
| September 30, 2023 | 286.11M |
| June 30, 2023 | 293.88M |
| March 31, 2023 | 263.42M |
| December 31, 2022 | 274.87M |
| September 30, 2022 | 252.60M |
| June 30, 2022 | 254.15M |
| March 31, 2022 | 240.18M |
| December 31, 2021 | 270.06M |
| September 30, 2021 | 253.22M |
| June 30, 2021 | 264.48M |
| March 31, 2021 | 247.60M |
| December 31, 2020 | 269.56M |
| September 30, 2020 | 240.08M |
| June 30, 2020 | 182.21M |
| March 31, 2020 | 242.40M |
| December 31, 2019 | 287.59M |
| September 30, 2019 | 268.61M |
| June 30, 2019 | 277.17M |
| March 31, 2019 | 250.80M |
| December 31, 2018 | 296.98M |
| September 30, 2018 | 272.08M |
| Date | Value |
|---|---|
| June 30, 2018 | 287.50M |
| March 31, 2018 | 250.40M |
| December 31, 2017 | 278.36M |
| September 30, 2017 | 251.25M |
| June 30, 2017 | 255.84M |
| March 31, 2017 | 226.82M |
| December 31, 2016 | 61.57M |
| September 30, 2016 | 295.27M |
| June 30, 2016 | 321.05M |
| March 31, 2016 | 286.97M |
| September 30, 2015 | 67.52M |
| July 31, 2015 | 81.01M |
| June 30, 2015 | 81.01M |
| April 30, 2015 | 74.07M |
| January 31, 2015 | 72.07M |
| October 31, 2014 | 73.42M |
| July 31, 2014 | 72.00M |
| April 30, 2014 | 74.85M |
| January 31, 2014 | 68.19M |
| October 31, 2013 | 70.10M |
| July 31, 2013 | 68.87M |
| April 30, 2013 | 68.34M |
| January 31, 2013 | 62.70M |
| October 31, 2012 | 62.96M |
| July 31, 2012 | 60.32M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
182.21M
Minimum
Jun 2020
318.58M
Maximum
Jun 2024
268.21M
Average
267.02M
Median
Revenue (Quarterly) Benchmarks
| Globus Medical Inc | 625.70M |
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 10.35M |
| Xtant Medical Holdings Inc | 27.94M |
| Catheter Precision Inc | 0.096M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 32.95M |
| Total Expenses (Quarterly) | 282.50M |
| EPS Diluted (Quarterly) | 0.60 |
| Enterprise Value | 3.083B |
| Gross Profit Margin (Quarterly) | 70.81% |
| Profit Margin (Quarterly) | 10.36% |
| Earnings Yield | 0.82% |
| Operating Earnings Yield | 3.37% |
| Normalized Earnings Yield | 4.255 |